Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 26;111(2):294-300.
doi: 10.1016/j.bpj.2016.06.015.

A Molecular Model for Lithium's Bioactive Form

Affiliations

A Molecular Model for Lithium's Bioactive Form

Katharine T Briggs et al. Biophys J. .

Abstract

Lithium carbonate, a drug for the treatment of bipolar disorder, provides mood stability to mitigate recurrent episodes of mania and/or depression. Despite its long-term and widespread use, the mechanism by which lithium acts to elicit these psychological changes has remained unknown. Using nuclear magnetic resonance (NMR) methods, in this study we characterized the association of lithium with adenosine triphosphate (ATP) and identified a bimetallic (Mg·Li) ATP complex. Lithium's affinity to form this complex was found to be relatively high (Kd ∼1.6 mM) compared with other monovalent cations and relevant, considering lithium dosing and physiological concentrations of Mg(2+) and ATP. The ATP·Mg·Li complex reveals, for the first time, to the best of our knowledge, that lithium can associate with magnesium-bound phosphate sites and then act to modulate purine receptor activity in neuronal cells, suggesting a molecular mode for in vivo lithium action.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mode of Li+ binding to ATP·Mg. (A) Schematic representation of ATP with Mg2+ bound to the β and γ phosphates is shown. (B) Three possible modes of Li+ binding to ATP·Mg (phosphates, red; Mg2+, blue; Li+, green) are shown. Scheme 1 represents Lif + ATP·Mg → ATP·Mg + Lif. Scheme 2 represents Lif + ATP·Mg → ATP·Li + Mgf. Scheme 3 represents Lif + ATP·Mg → ATP·Mg·Li. (C) Representative 7Li T1 relaxation data in the absence (open circles) and presence (closed circles) of 50 μM MnCl2 in a sample of 10 mM ATP, 11 mM MgCl2, and 10 mM LiCl; smooth curves are single-exponential fits.
Figure 2
Figure 2
Measured affinity of Li+ binding to ATP·Mg, ADP·Mg, and TP·Mg. 7Li T1 relaxation times (black circles) measured for 2 mM LiCl at 10°C as a function of the concentration of (A) ATP·Mg, (B) ADP·Mg, or (C) TP·Mg are shown. Fits using a quadratic binding equation (curves) yielded Li+ equilibrium dissociation constants, Kd: 1.60 ± 0.21 mM for ATP·Mg; 3.24 ± 0.56 mM for ADP·Mg; and 0.71 ± 0.23 mM for TP·Mg (reported uncertainties are standard errors calculated from least-squares fitting). Sample integrity was monitored using 31P NMR (Fig. S4). (D) A proposed molecular model for the ternary ATP·Mg·Li complex is shown. Mg2+ is 6-coordinate, with the β and γ phosphate oxygens replacing two water molecules. Li+ is 4-coordinate, with a γ phosphate oxygen replacing one water and a water bridge shared with Mg2+. To see this figure in color, go online.
Figure 3
Figure 3
Intracellular Ca2+ signals evoked by stimulating neuronal purinergic receptors with ATP, ATP·Mg, ATP·Li, and ATP·Mg·Li. (A) Schematic representation of purinergic receptors on the cell surface: P2X receptors are ion channels that permit influx of Ca2+ ions when activated by purinergic ligands like ATP; P2Y receptors are G-protein-coupled and trigger Ca2+ release from intracellular stores when activated by ATP. (B) Ca2+ signals are reliably triggered by consecutive 20 s pulses of 100 μM ATP. Repeated responses in the same cell are not significantly different (compare 1st and 2nd responses: t100-20 = 114, 112 s, respectively, p = 0.83, n = 9). (C) Ca2+ signals elicited by 20 s pulses of 100 μM ATP·Mg, 100 μM ATP, or 100 μM ATP·Li. ATP·Li without Mg2+ lengthens the Ca2+ response by 39% (compare 2nd and 3rd responses (ATP vs. ATP·Li, [Mg2+] = 0 mM): mean t100-20 = 139, 193 s, respectively, p = 0.015, n = 12). (D) Ca2+ responses evoked by 20 s pulses of 100 μM ATP·Mg or 100 μM ATP·Mg·Li. Response evoked by ATP·Mg·Li was longer than that evoked by ATP·Mg by 2.2-fold (compare 1st and 2nd responses (ATP·Mg vs. ATP·Mg·Li): t100-20 = 86, 191 s, respectively, p = 2.4 × 10−5, n = 20; compare 1st and 3rd response (1st ATP·Mg vs. 2nd ATP·Mg; internal control): t100-20 = 86, 88 s, respectively, p = 0.78, n = 20). (E) Ca2+ responses triggered by 100 s pulses of 100 μM ATP·Mg or 100 μM ATP·Mg·Li in Ca2+-free buffer. The P2Y component of ATP response does not depend significantly on Li+ (compare 1st and 2nd responses (ATP·Mg vs. ATP·Mg·Li): t100-20 = 41, 50 s, respectively, p = 0.17338, n = 28; compare 1st and 3rd responses (1st ATP·Mg vs. 2nd ATP·Mg; internal control): t100-20 = 41, 38 s, respectively, p = 0.73, n = 28). In panels BD, extracellular Ca2+ was 2.5 mM. Application of Li+ alone elicited no response (not shown).

References

    1. Pearson I.B., Jenner F.A. Lithium in psychiatry. Nature. 1971;232:532–533. - PubMed
    1. Cade J.F.J. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 1949;2:349–352. - PubMed
    1. Frausto da Silva J.J., Williams R.J. Possible mechanism for the biological action of lithium. Nature. 1976;263:237–239. - PubMed
    1. Schwarzenbach G., Kampitsch E., Steiner R. Komplexone III1. Uramil-diessigsäure und ihr Komplexbildungsvermögen. Helv. Chim. Acta. 1946;29:364–370.
    1. Birch N.J., Goulding I. Lithium-nucleotide interactions investigated by gel filtration. Anal. Biochem. 1975;66:293–297. - PubMed

LinkOut - more resources